CFT8634 is an oral activity degrader targeting BRD9 extracted from patent WO2021178920A1 compound 174. CFT8634 can be used for the research of synovial sarcoma and SMARCB1-deleted solid tumors[1][2].
Molecular Weight:
710.79
Purity:
98.60
CAS Number:
[2704617-96-7]
Formula:
C37H45F3N6O5
Target:
Epigenetic Reader Domain
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted